Saturday, November 3, 2012

India - Research - Industry collaboration - Development in Pharmaceutical Sector

The Alathur Pharmaceutical Manufacturers Association (APMA) in Tamil Nadu and the Central Drug Research Institute under the Council of Scientific & Industrial Research (CDRI-CSIR) signed a memorandum of understanding (MoU) to carry out combined research & development activities in formulations of chemicals and nutraceuticals of natural and synthetic origins, in a broad ranging cooperation basis.


As per the agreement, both the parties, APMA and CDRI-CSIR, will transfer knowledge of technology, scientific researches and other technical facilities as solutions to the troubleshooting problems in formulation development, analytical development and manufacturing of bulk drugs for all the member units in the pharma cluster to be established at Alathur.

The MoU was signed by Dr Rajendra Prasad, chief scientific officer of CDRI-CSIR, Lucknow and S Lekshminarayanan, secretary of APMA in the presence of Dr Anil Kumar Saxena, nodal scientist for MSME pharma cluster.

Regarding the agreement, the officials of the MSME and CSIR held discussion with the members of the Cluster project at Alathur two months ago. According to them development of cluster is the union health ministry’s initiative to help the small and medium scale pharma units in the country in finding remedies for their serious problems. The MoU suggests that CDRI should provide necessary technological support for the units established at the Alathur pharma estate. Further, the institute will give training to the cluster members in R&D and to conduct seminars for awareness on how to operate the cluster.

“The purpose of the agreement is to establish mutual interest between the pharma cluster and the CSIR-CDRI for facilitating technological interventions to enhance the innovation capacities of the MSME units. It will help both the organisations for collaboration in areas of common interest by participating in their academic, scientific and research activities,” said Lekshminarayanan.

According to him, they will jointly carry out combined research and development activities and mutually assist in pharmaceutical formulations in novel drug delivery system, and on new or improved process of known products of synthetic and plant origin. Together, the organisations will develop scientific collaboration with national and international universities and exchange their faculties for knowledge sharing.

Article Source: http://pharmabiz.com/NewsDetails.aspx?aid=71962&sid=1
Publication Date: 02 November 2012


No comments:

Post a Comment

Twitter / visalvalli

Journal of Electrochemical Society: Corrosion, Passivation, and Anodic Films - Current Issue

ScienceDirect Publication: Corrosion Science

CORROSION

Latest Issue of Corrosion Engineering, Science and Technology

Emerald | Anti-Corrosion Methods and Materials

CDA: What's New on Copper.org

ASTM International - New Standards for Corrosion and Wear

ASTM International - New Standards for Committee G01